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Abstract
Dendritic cells in the circulation are leukocytes that are rich
in Ia antigens and that actively stimulate T cell replication.
We have identified dendritic cells in the joint effusions of
patients with rheumatoid arthritis. By phase-contrast and
immunofluorescence microscopy, synovial mononuclear cells
contained 1-5% dendritic profiles that were rich in HLA-DR
and DQ, had small amounts of C3bi receptor, and lacked a
battery of monocyte and lymphocyte markers. These dendritic
cells could be enriched to 604-0% purity by cytolytic depletion
of monocytes and lymphocytes with a group of monoclonal
antibodies (MAb) and complement. By transmission electron
microscopy, the dendritic cell processes were bulbous in shape
and lacked organelles. The cytoplasm had few lysosomes or
endocytic vacuoles but contained a well-developed smooth
reticulum that was comparable to that previously described in
the ia-rich interdigitating cells of lymphoid tissues. The growth
of sodium periodate-modified T lymphocytes was used as a
rapid quantitative assay of accessory cell function. Synovial
mononuclear cells were some ten times more active than normal
blood cells. Treatment with a-Ia MAband complement ablated
stimulatory function. In contrast, removal of monocytes (MAb,
3C10) or monocytes and B (MAb, BA-i) plus T (MAb, OKT3,
or T101) lymphocytes did not significantly alter total activity,
and the function per viable cell increased four- to eightfold.
Weconclude that rheumatoid arthritis synovial fluids contain
cells that are comparable in function, phenotype, and structure
to blood dendritic cells, although the frequency (1-5%) is 10
times greater in joints. The reason for their accumulation in
the articular cavity is not known, but dendritic cells may be
important in perpetuating the joint inflammation characteristic
of this disease.
Introduction
The process that initiates rheumatoid arthritis (RA)' is un-
known, but its perpetuation appears to depend on immuno-
logically mediated events (1). Immune competent cells and
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1. Abbreviations used in this paper: C', complement; DC, dendritic
cell; FCS, fetal calf serum; MAb, monoclonal antibody; MLR, mixed
leukocyte reaction; RA, rheumatoid arthritis.
their products are abundant in the membrane lining the joint
and in the synovial fluid. A majority are polymorphonuclear
cells, but 15-20% are mononuclear. Of these, T cells predom-
inate. They differ from blood T lymphocytes in that the
majority are T8' and show many features of activation includ-
ing surface Ia antigens (2-5). Rheumatoid effusions also contain
unusual cytotoxic cells that lack Fc receptors and other markers
of conventional natural killer or cytotoxic T lymphocytes.
These cytotoxic cells appear to be derived from activated joint
T cells (6, 7). Somewhat surprising, in view of their activated
status, is the finding that RA synovial fluid T cells respond
poorly to lectins and autologous or allogeneic cells (8-13).
Synovial non-T cells on the other hand are potent stimulators
in the mixed leukocyte reaction (MLR) and usually cause
several times more proliferation of autologous blood T lym-
phocytes than do blood non-T cells (13-15).
A distinctive leukocyte, the dendritic cell (DC), seems to
be the principal stimulator of resting T lymphocytes as in the
MLRand oxidative mitogenesis, the proliferation of periodate-
modified T cells (16-20). DCwere described originally in mice
on the basis of novel cytologic features (21). The cells are
nonphagocytic and lack several surface markers of macrophages,
T and B lymphocytes, but they display large amounts of
surface Ia and class I antigens that would contribute to their
efficacy as stimulator cells (22-25). In several tissues and
species, accessory function is diminished by procedures that
deplete DCand are increased by methods that enrich for DC
(16-20). These observations have been confirmed in mice with
a specific a-DC monoclonal antibody (MAb; 16, 17, 26).
Unfortunately, such an antibody does not exist for the human
DC. Examination of their role as accessory cells has required
the specific elimination of other cell types. In the past, when
this has been done, the results have been compatible with the
data in mice; namely, depletion of monocytes or lympho-
cytes with specific MAb and complement (C) produces no
loss in stimulatory capacity for several T cell proliferative re-
sponses (19).
As noted above, the non-T cell fraction of RA synovial
effusions are strong stimulators of MLR's. Thus, it is reasonable
to look for DC in RA exudates. An added stimulus for these
investigations is the knowledge that the RAjoint lining contains
Ia-rich cells (26-30), and some assume a stellate appearance
in tissue culture (31-33). By using techniques developed for
the study of human blood DC (23, 24), we have shown that
RA effusions contain relatively large numbers of cells that are
similar to blood DC in morphology, phenotype, and accessory
function. These exudate DC are probably distinct from the
stellate cells derived from RA synovial membrane.
Methods
Subjects. Patients having RA met the American Rheumatism Associ-
ation criteria for classical RA (34). All but one was receiving treatment
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at the time of study; the majority were on disease modifying agents
(gold, penicillamine, chloroquine) and the remainder on corticosteroids
or nonsteroidal antiinflammatory agents. One patient (J.H.) had an
asymmetric, oligoarticular, seronegative, large-joint arthritis associated
with psoriasis. All patients and controls provided blood and/or joint
samples with informed consent.
Culture medium, serum. The complete medium was RPMI 1640
(Gibco Laboratories, Grand Island, NY) supplemented with 1 mM
glutamine, 5 X 1-0 2-mercaptoethanol, 100 U/ml penicillin, 20 Ag!
ml gentamicin, and 5- 10% fetal calf serum (FCS; HyClone Laboratories,
Sterile Systems, Logan, UT, 560C, 30 min). Human serum was
prepared from 1 U of whole AB' blood with no additives (Greater
New York Blood Center) after 4 h of clotting at 4VC, clarification by
centrifugation, and storage at -70'C.
Synovial fluid mononuclear cells. Synovial fluid was obtained by
aseptic joint aspiration into sterile heparinized tubes or syringes (10
U/ml) and allowed to stand at room temperature for 30-60 min. A
few samples were treated with 1.5 U/ml hyaluronidase (Wydase; Wyeth
Laboratories, Marietta, PA) for 30 min at 370C to reduce viscosity. In
previous experiments, hyaluronidase did not influence stimulatory
capacity for the autologous MLR(8). Mononuclear cells were isolated
on Ficoll-Hypaque columns, washed three times in RPMI plus 10%
FCS, and cultured on 100-mm plastic petri dishes (Falcon Labware,
Becton, Dickinson & Co., Oxnard, CA) in complete medium (above)
with 5%FCS (5-20 X 106 cells/dish). In studies of adherence properties,
mononuclear cells were plated for 1-3 h at 370C, and the nonadherent
cells were dislodged by swirling and several washes. The adherent cells
constituted 10-70% of the total and could be removed by vigorous
pipetting with cold RPMI 1640. When the entire synovial mononuclear
population was cultured overnight, >80% of the cells detached, and
the remainder could be removed with vigorous pipetting. These were
designated as overnight or day I nonadherent and adherent populations,
respectively. Since adherence did not prove to be useful in enriching
for synovial accessory function (see Results), we generally combined
the cultured adherent and nonadherent fractions before further study.
Blood mononuclear cells. Heparinized blood was taken from normal
volunteers or was purchased as buffy coats from the Greater New
York Blood Center. Mononuclear cells were separated on Ficoll-
Hypaque columns, and adherent cells were selected after 1-3 h of
culture (5 X 106 cells/100-mm plastic petri dishes) in complete medium
with 5% FCS. Adherent cells typically represented 20-40% of the total
and were comprised of 50-70% monocytes, 20-40% B cells, 10-20%
T cells, and 1-4% DC. After overnight culture, 60-80% of the ad-
herent cells detached, and these were used as an active stimulator popu-
lation (23).
Phagocytosis of latex particles. Latex particles (1.1 Am, Dow
Chemical Co., Indianapolis, IN) were used to detect phagocytosis at a
cell/particle ratio of 1:100. 2 X 106 synovial fluid cells that were
isolated from fresh effusions were mixed with opsonized latex (40%
AB serum, 1 h, 40C) in 2 ml 10% FCS RPMI 1640. The cells and
particles were centrifuged (400 g, 5 min, 20'C) to facilitate contact,
and phagocytosis was allowed to occur for 1 h at 370C. Free latex was
removed by washing the mixture twice with RPMI 1640 at 200 g, 5
min each time. Cells were then attached to poly-L-lysine coated
multiwell slides and examined by phase-contrast and immunofluores-
cence microscopy as described below.
T cell proliferation assays. Graded doses of viable, irradiated (3,000
rads, I'`Cs) stimulator cells were added to 1.5 X 105 periodate-modified
T cells (oxidative mitogenesis) in 6-mm flat wells (No. 3596; Costar,
Data Packaging Corp., Cambridge, MA) in medium with 10% human
AB' serum. T cells were nylon wool nonadherent blood mononuclears
that were treated with a-monocyte (3C10) and a-Ia (9.3FI0) MAband
C as described (24). T cells were either unrelated or syngeneic to the
donor, and were modified with 1.2 mMsodium periodate in phosphate-
buffered saline (PBS) for 15 min on ice, spun at 900 rpm for 10 min
at 4VC, and washed once in RPMI 1640. [3H]Thymidine uptake was
measured at 48-64 h (4 MCi/ml) and data displayed as mean counts
per minute of triplicates±SEM. Controls were < 1,000 cpm and included
nonperiodate-modified T cells cultured with stimulators, periodate T
cells without stimulators, and stimulators only.
Treatment with MAb and C'. Equal volumes of cells and MAb
were kept on ice for 20-40 min. Another volume of rabbit C was
added and the mixture incubated 45-60 mim at 370C. All reagents
were diluted in RPMI, 0.3% bovine serum albumin, 25 mMHepes
buffer, and 10 Ag/ml deoxyribonuclease (type I; Sigma Chemical Co.,
St. Louis, MO). The final concentrations were 1.6-2.5 X 106/ml for
cells, 1-10 Mg/ml for MAb, and 1:9 for rabbit serum reconstituted
from Iyophilized samples from selected rabbits. After treatment, the
cells were washed three times and used in oxidative mitogenesis assays.
The depletion of specific subsets of leukocytes was monitored by
immunofluorescence with alternative MAb to that subset (see Table
I). For monocytes, we used 631)3; for B cells IF5; and for T cells,
OKT3 or Tl 1. Monocyte depletion was also apparent by cytologic
criteria.
Immunofluorescence. All reagents were diluted in RPMI with 5%
horse serum (Gibco Laboratories) and 0.02% sodium azide. MAbwere
obtained from commercial sources and/or have been described elsewhere
(Table I). 3 X 104 cells in 20 MAl RPMI were attached at 40C to poly-
L-lysine coated multiwell slides (24). The cells were then exposed on
ice to MAb for 60 min, rinsed in PBS, exposed to biotinyl horse
a-mouse IgG (Vector Laboratories, Burlingame, CA) at 50 Mg/ml for
30 min, overlaid with fluorescein avidin (Vector Laboratories) at 100
jg/ml for 30 min, rinsed, fixed in 10% formalin/PBS for 20 min,
mounted in glycerol, and viewed by phase-contrast and fluorescence
microscopy. This technique allowed us to evaluate staining with a
large number of MAbusing only small numbers of cells. DCprepared
in this manner displayed an irregular cell shape but the cytologic detail
and extent of spreading on multiwell slides, processed for fluorescence
microscopy, was less clear than that described previously for glass
coverslips (19, 23).
Transmission electron microscopy. Cells were washed, fixed in a
fresh mixture of 2.5% glutaraldehyde (Polysciences Inc., Warrington,
PA) in 0.1 M sodium cacodylate buffer (pH 7.4) containing 0.1 M
sucrose, rinsed in saline, and then postfixed with 1%osmium tetroxide.
Samples were stained with 0.25% uranyl acetate, dehydrated in graded
alcohols, and embedded in Epon. Two populations of synovial mono-
nuclear cells were examined: control cells, which were exposed to
complement only or left untreated; and DC, which were enriched by
monocyte and lymphocyte elimination as described in Results.
Results
Synovial fluid mononuclear cells stimulate the oxidative mito-
genesis of T cells. Evidence that synovial effusions contained
DCcame first from assays of accessory or stimulator function.
The assay was the oxidative mitogenesis or proliferation of T
lymphocytes modified with sodium periodate (36, 37). When
T cell surface carbohydrates are oxidized to form aldehydes,
the lymphocytes will proliferate actively upon addition of
accessory cells, particularly DC (17-19). This system has the
additional advantages that no distinction is made between
allogeneic and syngeneic stimulators and maximal proliferation
occurs at - 72 h.
In the initial experiments, unfractionated RAsynovial fluid
mononuclear cells were compared with normal adherent blood
populations. RAcells were at least threefold better as stimulators
of oxidative mitogenesis (Table II), regardless of the type of
therapy the patients were taking. Since adherent cells represent
1/3 of total blood mononuclears but have the bulk (60-90%) of
the accessory activity (19), we conclude that synovial exudate
mononuclears are some 10 times better as stimulators than
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Table L Monoclonal Mouse Anti-human Leukocyte Antibodies
Name Ig subclass Source Polypeptide Specificity
mol WI
9.3F10 IgG2. Van Voorhis (24) 34/29,000 HLA-DR & DQ"
OKla IgG2 Ortho Diagnostic Systems, Inc., Johnson & 34/29,000 HLA-DR
Johnson, Raritan, NJ
Leu-10 IgG1 Ortho Diagnostic Systems, Inc. 32/29,000 HLA-DQ
OKM1 IgG2b Ortho Diagnostic Systems, Inc. 170,000 C3bi receptor
63D3 IgG1 Bethesda Research Laboratories, 200,000 Monocytes
Gaithersburg, MD
3C10 IgG2b Van Voorhis (24) 55,000 Monocytes
3G8 IgG1 Fleit (51) 48-60,000 Fc receptor
T101 IgGd Hybritech Inc., La Jolla, CA 65,000 T cells
OKT3 IgGa Ortho Diagnostic Systems, Inc. 19,000 T cells
IF5 IgG2. Clark (50) 35,000 B cells
BA-1 IgM Hybritech Inc. NA§ B & granulocytes
OKT6 IgG1 Ortho Diagnostic Systems, Inc. 52,000 Thymocytes, Langerhans cells
Leu-7 (HNKI) IgM Becton-Dickinson & Co., Oxtiard, CA 110,000 NK cells
HL IgG1 Posnett (35) 52-63,000 Hairy cell leukemia
activated B cells
8C4* IgM Dr. Steinman, The Rockefeller University NA ?HLA-DQ
4B2t IgG Dr. Steinman, The Rockefeller University 200,000 Leukocyte antigen
* 8C4 is a new MAb that reacts primarily with DCand B cells in blood and tonsil suspensions and with interdigitating cells and B cells in
lymphoid tissue sections. t 4B2 reacts with all blood and joint leukocytes but not platelets, fibroblasts, endothelium, and several epithelia (un-
published). § NA, not available. 1l Recent studies (unpublished) indicate that 9.3F10 identifies an epitope found on both DRand DQ.
unfractionated blood mononuclears. However, periodate-treated
T cells from RA and normal individuals responded similarly
to autologous or allogeneic blood stimulators (data not shown).
The adherence properties of the synovial stimulators were
evaluated at varying times in culture. The specific activity of'
freshly prepared, adherent populations was greater than the
nonadherent fraction, but a substantial (50% or more) amount
of the total activity was nonadherent. At subsequent time
Table II. A Comparison of Synovial and Blood Cells as Stimulators of Oxidative Mitogenesis
Proliferation to graded doses of stimulators
Synovial cells (X 101) Blood cells (X 104)
Experiment Test day 5.0 1.6 0.5 0.16 5.0 1.6 0.5 0.16
cpm [3H]TdR X 1JO cpm [3H]TdR X 10-3
I 0 19.0 12.0 7.3 2.2 9.2 3.8 1.6 -
2 1 78.2 61.9 43.3 22.5 57.2 28.9 16.4 4.2
3 2 36.8 22.8 12.0 2.9 22.1 9.9 3.2 -
4 1 57.5 38.4 21.3 4.8 47.5 25.6 9.7 1.8
1.5 X 105 periodate-treated cells were cultured with graded doses of irradiated unfractionated mononuclear cells, derived from synovial fluid
after 0, 1, or 2 d of culture, or plastic adherent blood cells also used after 0-2 d of culture. The T cells were autologous to the blood non-T
cells and allogeneic to the synovial cells in experiments 1, 2, and 4. In experiment 3, both of the stimulator populations were allogeneic to the
periodate T cells.
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Table III. Accessory Function of Adherent or Nonadherent
Synovial Fluid Cells after Various Times in Culture
Proliferation to graded doses of
Synovial fluid stimulator cells stimulators X 101
Test
Patient day Fraction 5.0 1.6 0.5 0.16
cpm 3H-TdR X 1O'
F.McG. 0 Total 27.2 10.8 2.6 1.8
(RA) 0 Adherent 46.1 34.9 12.6 2.5
0 Nonadherent 11.6 3.6 2.6 1.5
A.P. (RA) 0 Adherent 13.5 3.7 1.2
0 Nonadherent 7.5 4.6 1.6 1.2
J.H. (PSA) 1 Adherent 31.6 27.3 8.4
1 Nonadherent 21.0 10.5 1.1
M.R. No. I I Adherent 58.8 39.4 13.9 5.4
(RA) 1 Nonadherent 44.9 27.5 11.4 3.3
W.R. No. 2 1 Adherent 68.0 50.6 30.9 7.4
(RA) I Nonadherent 78.4 48.9 22.4 7.0
F.McG. 2 Adherent 41.1 24.9 11.5 6.9
(RA) 2 Nonadherent 52.5 39.3 24.9 12.9
The preparation of adherent and nonadherent stimulator cells is de-
scribed in Methods. PSA, psoriatic arthritis.
points (1-2 d), stimulating activity was again found in both
plastic adherent and nonadherent fractions (Table III). With
time in culture, the specific activity increased in the nonadherent
fraction, but the total activity was not significantly altered
(e.g., patient F.McG., Table III).
Cell surface markers of the stimulator cell in rheumatoid
effusions. To test if the stimulator in RA effusions expressed
surface antigens that were comparable to blood DC, stimulatory
activity was studied after treating synovial cells with MAband
rabbit C. Mononuclear counts were reduced <10% by Calone
(10 experiments); 32±17% with the monocyte specific MAb
Table IV. Accessory Function of Monocyte-depleted
Synovial Fluid Mononuclear Cells
Proliferation to graded doses of
Synovial fluid stimulator cells stimulators (X 104)
Patient Knee Treatment 5.0 1.6 0.5 0.16 0.05
cpm 3H-TdR X 10-
J.K. (RA) Left 3CGb/C' - 52.5 38.2 27.4 13.0
3C10/no C' 79.1 58.2 27.5 11.5 -
Right 3CIb/C' 48.1 21.0 17.4 5.8 2.4
3C10/no C' 37.3 17.8 5.7 1.6 -
1.5 X 101 allogeneic periodate-treated T cells were stimulated with graded doses
of irradiated synovial fluid mononuclear cells from each knee of a patient with
RA. Adherent synovial fluid cells were cultured overnight and treated with
3ClOa-monocyte MAb+C' before use. The extent of kill in the presence of C'












5 1.5 0.5 0.15
Stimulators x 10'
Figure 1. Stimulating activity of different synovial fluid populations
for oxidative mitogenesis. Nonadherent RA cells, after overnight
culture, were treated with C alone (o; 16% cell death), 3C10 a-
monocyte MAb(.; 53% cell death) or with 9.3F10 a-Ia MAb(t;
48% cell death).
3C10 plus C (6 experiments); and 85-95% (12 experiments)
with a "cocktail" of MAbto T cells (TO11 or OKT3), B cells
(BA-l or iF5), and monocytes (3C10). The efficiency of cell
depletion was always <90% and was verified by immunofluo-
rescence with additional MAb.
The effusions from both knees of a patient with RA were
studied (Table IV). Monocyte elimination did not reduce total
stimulatory capacity, and the specific activity of the surviving
cells was increased threefold. Of interest was the finding that
cells from the left knee, which was more inflamed than the
right (synovial fluid leukocyte counts of 27,500/mm3 and
1 3,800/mm3, respectively), were more stimulatory. In a second
patient (Fig. 1), elimination of cells bearing class II or Ia
antigens completely abrogated stimulating activity. In contrast,
cells surviving 3C10 and C retained activity and on a per cell
basis were about five times more active in provoking mitogenesis
than cells treated with C alone. Therefore, total accessory
function is not reduced by monocyte depletion, and specific
activity may be increased when monocytes represent a large
fraction of total mononuclear cells.
Since RA effusions contain activated T cells and B lym-
phocytes, both of which display Ia antigens, stimulatory activity








5 1.5 0.5 0.15
Stimulators x 104
Figure 2. Similar to Fig. I except that nonadherent synovial cells
were studied after 2 d of culture and were treated with C alone (o;
14% cell death), 3C10 a-monocyte MAb(-; 33% killing), or a
cocktail of a-monocyte and B and T cell MAb(A; 90% killing).
792 N. J. Zvaifler, R. M. Steinman, G. Kaplan, L. L. Lau, and M. Rivelis
Figure 3. The phenotype of mononuclear cells in the plastic adherent
fraction of synovial eflusions. Cells were attached to glass slides and
stained with MAb. The same field was photographed with phase
contrast (left) and fluorescence (right) microscopy. Conditions for the
exposure and development of the micrographs were similar. By phase
contrast (X 625), each sample contained a major population of large
round cells and minor populations of small round cells (lymphocytes,
white arrows) and spiny cells (DC, black arrows). By immunofluores-
cence (right) the following occurred: (A) 8C4 stained DCbrightly
(white arrowhead) and some small presumed B cells weakly. (B)
OKM1 (a-C3bi receptor) stained most synovial cells except for some
of the lymphocytes. The DC (white arrowheads) showed weak reac-
tivity. (C) 9.3F10 (a-HLA DRand DQ) stained most synovial cells,
but the DCwere especially bright (white arrowheads). (D) BA-1 (a-B
cell) did not stain DC (white arrowhead) but did react with a few
round cells. (E) 63D3 (a-monocyte) stained most large round cells
but not the lymphocytes or DC (white arrowheads). Identical results
were observed with 3C10, another a-monocyte reagent.
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lymphocytes with an appropriate mixture of MAb. Although
85-95% of the mononuclear cells were killed, the residual
population retained stimulatory activity and on a per cell basis
was 4-10-fold more active than the same cells treated with C'
alone (4 experiments). One such study is shown in Fig. 2,
where it can be seen that there was a slight enhancement of
stimulatory activity when monocytes (14% of the mononuclear
cells) were depleted, and a seven- to eightfold increase when
both lymphocytes and monocytes were removed.
Identification of synovial fluid dendritic cells. Adherent
synovial fluid cells were isolated after 1 or more d in culture,
attached to poly-L-lysine-coated slides, stained with MAb
using a biotin-avidin technique, fixed, and examined. By phase
contrast, the populations that were exposed to C only (Fig. 3)
consisted primarily of large round cells, most of which were
phenotyped as monocytes (3C 10, 63D3, OKM1, positive; BA-
1, lF5, OKT3, T101, HL, 3G8, HNK1, Leu 7, negative). A
few of the large cells were B cells (HL, BA-1, 1F5, positive)
and NK cells (HNKl and Leu 7, positive), and most of the
small cells were T lymphocytes (OKT3, T101, Tl 1, positive).
In addition, there was a minor (1-5%) population of spiny
cells or DCthat stained strongly with a-Ia (both DRand DQ),
weakly with OKM1 (a-C3bi receptor), but lacked monocyte,
B, T, and NK antigens as well as Fc receptors (e.g., Fig. 3).
The weak OKM1 staining of candidate DCwas confirmed on
blood DC. In earlier studies (23), this weak stain was not
appreciated because the lot of OKM1 that was available did
not react as strongly with monocytes as the current lot. Most
of the synovial fluid cells stained with a-DR antibodies, but
the DCwere stained the strongest (Fig. 3). The a-DQ reagent,
Leu 10, stained DCstrongly and presumed B cells weakly.
When similar experiments were performed on populations
that had been treated with 3C10, BA-1 and T101 MAb
(a-monocyte, B and T cell), and C', the bulk of the surviving
cells were dendritic in shape (Fig. 4). Their surface phenotype
was Ia' and 4B2+ (leukocyte common antigen) but negative
for 63D3, 3C10, OKT3, 1F5, HNK, HL, and 3G8 antigens
(e.g., Fig. 5). Neither control nor DC-enriched populations
stained with the a-Langerhans cell/thymocyte reagent, OKT6
(not shown).
A particularly interesting MAbwas 8C4, which is a new
reagent that has some similarities with a-HLA DQantibodies
like Leu 10, in that it stains blood DCstrongly, B cells weakly
or moderately, and monocytes weakly if at all. 8C4 also stained
the candidate DC in synovial effusions (Fig. 3) and most of
the cells that survived lysis with a-monocyte and lymphocyte
MAb (Fig. 5). We conclude that there are DC in synovial
effusions that express the same cell surface antigens as their
counterparts in blood; namely, positive for DR, DQ, and
leukocyte antigens and weakly positive for OKM1. In fact,
synovial DCtypically could not be distinguished from parallel
samples of adherent blood DC except that the synovial cells
could be larger in size.
Phagocytosis by synovial fluid mononuclear cells. Mono-
nuclear cells that appeared to be monocytes by phase-contrast
microscopy phagocytosed large numbers of latex particles,
whereas small round (T) and dendritic cells did not (Fig. 6 A).
The phagocytes were verified to be monocytes by virtue of
staining with the cell-specific MAb, 63D3 (Fig. 6 B). The
nonphagocytic DCdid not stain with 63D3 (Fig. 6 B) but did
stain with the 8C4 MAb(not shown).
Electron microscopy. Four samples of synovial fluid mono-
nuclear cells, obtained after 1-3 d of culture, were examined
by transmission electron microscopy with or without enrich-
ment for DC. The control populations were comprised primarily
of typical macrophages and lymphocytes. The macrophages
contained many large endocytic vacuoles filled with debris
(arrows, Fig. 7). In contrast, most of the cells in the DC-
enriched fraction (verified to be depleted of monocytes and
lymphocytes by immunofluorescent staining) resembled blood
DC with the exception that the cytoplasm contained large
numbers of organelles (Fig. 8). The nuclei were large and
irregularly shaped and had a peripheral rim of heterochromatin
and small nucleoli. There were many mitochondria with
associated profiles of rough endoplasmic reticulum. Lysosomes
were few to moderate in number, pinocytic vesicles were
infrequent, and the Golgi saccules were few and short. Birbeck
granules were not found.
Several distinctive features of synovial fluid DCwere best
appreciated at higher magnification (Fig. 9). One was a well-
-rFigure 4. The dendritic ap-
pearance of the majority of
viable synovial cells surviving
treatment with a-monocyte
and ai-lymphocyte MAband
C'. Most of the small roundEu, ~~~~~~~~~profiles are nuclei of thelysed cells. (X 1,000.)
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Figure 5. Enrichment of synovial DCfrom cultured (2 d) nonadherent populations by depletion of monocytes and lymphocytes. Under phase
contrast (lefit), most of the profiles are irregularly shaped DCwhile smaller profiles are dead cells. By immunofluorescence (right), the DCare
8C4' (A), 9.3F10 or Ia+ (B), HNK-I- (C), and hairy cell/B lymphoblast negative (D).
developed smooth reticulum consisting of short tubular profiles tinctive, being covered with blunt processes of varying length.
with an electron-dense content. The profiles were especially The processes contained a fine matrix that excluded organelles.
frequent in the perinuclear zone and resembled comparable Coated pits and vesicles were not observed.
structures in interdigitating cells (39, 40), the presumed in situ
counterparts of DC in sections of lymphoid organs. Another Discussion
feature that was not seen in synovial monocytes and lympho-
cytes were large bundles of intermediate filaments that fre- The joint effusions from patients with RA contain cells that
quently swept around the nucleus. The DC surface was dis- are similar to the DC in human blood (20, 23, 24) and in
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Figure 6. Latex phagocytosis by monocytes from synovial effusions. By phase contrast (A), most of the cells are small round lymphocytes.
Some
of the larger cells have phagocytosed the refractile latex particles and are monocytes, since they stained with 63D3
a-monocyte MAb(B). Two
DC (black arrows) are nonphagocytic and 63D3-. (X 1,000.)
or42
I
Figure 7. Electron micrograph (low power) of two synovial fluid macrophages to illustrate the many endocytic vacuoles
filled with content
(arrows). (X 14,000.)







Figure 8. Electron micrograph (low power) of a synovial DCenriched by depleting lymphocytes and macrophages. The surface is covered with
knoblike protrusions. The cytoplasm has many mitochondria and thick bundles of microfilaments (x). The Golgi stacks are not prominent, but
the Golgi region is filled with narrow, smooth, membrane-bound profiles and some lysosomes (Ly). Cisternae of rough endoplasmic reticulum
are in the cell periphery (arrows). (X 17,000.)
lymphoid organs of other species (18, 39, 41). By phase
contrast, we have noted a subpopulation of irregularly shaped
mononuclear cells that had the same surface markers as DC
in normal blood (Ia-rich; C3bi-receptor weak; monocyte, lym-
phocyte, and NK differentiation antigen negative; Fig. 3).
Whenmonocytes and lymphocytes were selectively eliminated,
exudate DC were enriched, as evidenced by phase-contrast
and surface markers (Figs. 4 and 5), by ultrastructure (Figs. 8
and 9), and by stimulatory function (Figs. 1 and 2, Table IV).
Whereas the majority of freshly isolated blood DC stuck to
plastic, synovial DC partitioned variably between adherent
and nonadherent populations (Table III). Therefore we focused
on cell depletion rather than adherence as an enrichment
technique.
Other cell types in joint effusions and in the synovial lining
could exhibit some features of DC. Synovial lining cells of RA
patients, for instance, are rich in HLA-DR antigens (27-30).
When synovial lining has been dispersed with proteolytic
enzymes, a variable number adhere to the surface of the
culture vessel and assume a distinctive stellate morphology
(31). Such cells are many times larger than the adherent
macrophages in the same culture and have dendritic processes
that extend for long distances (10-40 gM). A number of
findings suggest that collagenase-producing, stellate, synovial
cells are most likely related to fibroblasts (31) and include the
observation that after several passages, a typical fibroblast
morphology is assumed. The cells reassume the stellate form
if endogenous prostaglandin E2 (PGE2) production is stimulated
or if exogenous PGE2 is added (38). The studies of Burmester
et al. and Winchester and Burmester show that a proportion
of isolated synovial lining cells are nonphagocytic and do not
stain with MAbto lymphocyte, monocyte, or fibroblast antigens
(27, 32). This DR' population also assumes a stellate or
dendritic appearance, but in contrast to synovial fluid DC, the
former cells are larger and rapidly lose their long processes
and surface Ia (31). Poulter et al. (29) have likened some of
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Figure 9. Electron micrograph (high power) of a synovial DC to illustrate smooth-surfaced tubular profiles with electron-dense content (arrows),
surface processes that are filled with a fine fibrillar content (*), and bundles of intermediate-sized filaments (arrowhead). (x 45,000.)
the dendritic, DR-rich, non-T cells in the synovial membrane
to the interdigitating cells of the T areas of lymphoid organs
(39, 40). Some cells included in the heterogeneous population
of adherent, DR-rich synoviocytes can stimulate an allogeneic
MLR(28, 42). Optimum stimulation has been observed with
a concentration of adherent cells that is '/20-'/1ooth that for
blood non-T cells. Therefore it has been reasoned that the
synovial membrane population contains an active stimulator
cell as well as suppressor cells, possibly macrophages. In our
study of exudate cells, elimination of macrophages occasionally
produced a modest increase in total accessory function (Fig.
1), but the more typical observation was an increase in specific
activity that was proportional to the enrichment for synovial
fluid DC (Table IV, Fig. 2).
While blood DC appear to be the one cell with the same
constellation of features as synovial DC, their frequencies
differ, being 0.1-0.5% in blood (23) and 1-5% in synovial
effusions. Given their functional capacities, the increased fre-
quency of DC likely explains why synovial non-T cells are
more active stimulators of T cell proliferation than blood non-
T cells (8).
The mechanism for the accumulation of DCin joint fluid
is not clear. Information about the life history and traffic
patterns of DC is just beginning to emerge. DCoriginate from
a precursor in bone marrow and are found in small numbers
in blood. Sizable numbers of cells that resemble DCand are
often termed "veiled cells" have been found in afferent but
not efferent lymph (25, 43, 44). Therefore, a pool of DClikely
exists in nonlymphoid tissues and is capable of moving into
afferent lymph. The best example would be the epidermal
Langerhans cell, which is related to DC (45). It has been
postulated that Langerhans cells move via the lymph to nodes
to become the interdigitating or Ia-rich dendritic cells of T-
dependent regions (44). Therefore one possibility is that synovial
fluid DC are derived from cells that are normally present in
the synovial lining, and that egress via the lymph is altered
during arthritis leading to an accumulation or reflux into the
synovial cavity. Tyndall et al. have likened some of the cells
in synovial effiusions to the veiled cells in lymph (46). An
alternative is that synovial DCrepresent an influx from blood
as part of the inflammatory process.
Regardless of mechanism, the presence of DC in an
inflammatory site would be expected to intensify the local
immune response. DC are active stimulators of several T-
798 N. J. Zvaifler, R. M. Steinman, G. Kaplan, L. L. Lau, and M. Rivelis
dependent responses including the syngeneic MLR, the release
of lymphokines, the development of cytolytic T cells, and the
secretion of antibody to T-dependent antigens (16-20, 47, 48).
DCare particularly specialized to initiate responses in resting
helper T cells, whereas other cell types like macrophages and
B lymphocytes can interact with helper cells in the effector
limb of immunity (49, 52). Therefore, it is tempting to propose
that synovial DCcontribute to the intraarticular activation of
T cells that has been described in RA. The experience with
one patient with psoriatic arthritis (J.H., Table III) may
indicate that increased numbers of- synovial fluid DC will
accompany other forms of chronic joint inflammation. Studies
are in progress to address this point.
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